Srinivas Bandari

Synthesis of Quinoline‐Morpholine‐Coupled 1,2,3‐Triazole Hybrids as <i>In vitro</i> EGFR inhibitors

Annapurna Mamidala, Karthik Bokkala, Narasimha Swamy Thirukovela et al. · ChemistrySelect · 2022 · 17 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Design, Synthesis, and Molecular Docking Studies of Some New Quinoxaline Derivatives as EGFR Targeting Agents

Vinitha Badithapuram, Satheesh Kumar Nukala, Narasimha Swamy Thirukovela et al. · Russian Journal of Bioorganic Chemistry · 2022 · 15 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Design and synthesis of some new imidazole-morpholine-1,2,4-oxadiazole hybrids as EGFR targeting in vitro anti-breast cancer agents

Praveen kumar Kannekanti, Satheesh Kumar Nukala, Srinivas Bandari et al. · Journal of Molecular Structure · 2024 · 13 citations

Pharmacy, Medicinal Chemistry, Oncology +12

Design and Synthesis of Some New <i>N</i> -(Thiazol-2-yl) Benzamides of Quinoxaline as DNA Topoisomerase II Targeting Anticancer Agents and ADMET

Yellaiah Bonakolluru, Satheesh Kumar Nukala, Gouthami Dasari et al. · Polycyclic aromatic compounds · 2022 · 11 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Design and Synthesis of Some New Quinoxaline Containing 1,3,4-Oxadiazole Hybrids and Evaluation of Their Anti-Cancer Activity

Padma Kandukuri, Gouthami Dasari, Satheesh Kumar Nukala et al. · Russian Journal of Bioorganic Chemistry · 2022 · 11 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11